Incyte’s Acquisition of Villaris Therapeutics

Martina Bellini
Tagged:

Sidley represented Incyte on the deal.Incyte (NASDAQ:INCY) announced its agreement to acquire Villaris Therapeutics, a biopharmaceutical company focused on the development of novel antibody therapeutics. The company’s…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now